// App-Quantinova.ai

: Metabolomics Analysis of MSC Therapy in A Phase I Clinical Trial for Septic Shock

Researchers

Presenter

  • B. W. Winston

Principal Investigators

  • M. Banoei

  • L. McIntyre

  • D. J. Stewart

  • S. H. Mei

  • D. Courtman

  • I. Watpool

  • J. T. Granton

  • J. C. Marshall

  • C. C. Dos Santos

  • K. R. Walley

  • K. Schlosser

  • D. Fergusson

Medical Centers

  • Departments of Critical Care Medicine, Medicine and Biochemistry and Molecular Bilogy, Univ of Calgary, Calgary, AB, Canada,

  • University of Calgary, Calgary, AB, Canada

  • Medicine, Ottawa Health Research Institute, Ottawa, ON, Canada

  • Department of Cell and Molecular Medicine, Ottowa Health Research Inst, Ottawa, ON, Canada,

  • Sinclair Centre for Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Critical Care Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada,

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Medicine, UHN-Toronto General Hospital, Toronto, ON, Canada.

  • Department of Surgery and Critical Care Medicine, St Michaels Hosp, Toronto, ON, Canada,

  • Department of Medicine and Critical Care Medicine, University of Toronto, Toronto, ON, Canada,

  • Department of Medicine, Centre for Heart and Lung Innovation, Vancouver, BC, Canada,

  • Department of Epidemiology and Community Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT02421484

Sponsors

  • N/A

Result

  • N/A